<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-05198474</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-25T01:30:52+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Optimizing First‐Line Therapeutics in Non‐Small Cell Lung Cancer: Insights From Joint Modeling and Large‐Scale Data Analysis</title>
            <author role="crp">
              <persName>
                <forename type="first">Benjamin</forename>
                <forename type="middle">K</forename>
                <surname>Schneider</surname>
              </persName>
              <email type="md5">efd5d31bb6abacaff820a62dda788aca</email>
              <email type="domain">gmail.com</email>
              <idno type="idhal" notation="numeric">1569323</idno>
              <idno type="halauthorid" notation="string">1571428-1569323</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-5544-3499</idno>
              <affiliation ref="#struct-179944"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Sébastien</forename>
                <surname>Benzekry</surname>
              </persName>
              <email type="md5">058c3fc27bb7f758cba0c0195d61a833</email>
              <email type="domain">phare.normalesup.org</email>
              <idno type="idhal" notation="string">sebastien-benzekry</idno>
              <idno type="idhal" notation="numeric">12116</idno>
              <idno type="halauthorid" notation="string">9370-12116</idno>
              <idno type="ARXIV">https://arxiv.org/a/benzekry_s_1</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-3749-8637</idno>
              <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=xsLpdFAAAAAJ&amp;hl=fr&amp;oi=ao</idno>
              <idno type="IDREF">https://www.idref.fr/159344212</idno>
              <affiliation ref="#struct-1071285"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Jonathan</forename>
                <forename type="middle">P</forename>
                <surname>Mochel</surname>
              </persName>
              <idno type="idhal" notation="numeric">1211549</idno>
              <idno type="halauthorid" notation="string">1810566-1211549</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-0997-3111</idno>
              <affiliation ref="#struct-302747"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Sebastien</forename>
                <surname>Benzekry</surname>
              </persName>
              <email type="md5">6265406c2f4b74e0106bf0ba27675c40</email>
              <email type="domain">inria.fr</email>
            </editor>
            <funder ref="#projanr-98243"/>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2025-08-04 10:29:05</date>
              <date type="whenModified">2025-08-26 15:21:01</date>
              <date type="whenReleased">2025-08-04 11:20:20</date>
              <date type="whenProduced">2025-07-29</date>
              <date type="whenEndEmbargoed">2025-08-04</date>
              <ref type="file" target="https://inria.hal.science/hal-05198474v1/document">
                <date notBefore="2025-08-04"/>
              </ref>
              <ref type="file" subtype="publisherPaid" n="1" target="https://inria.hal.science/hal-05198474v1/file/Optimizing%20First-Line%20Therapeutics%20in%20Non-Small%20Cell%20Lung%20Cancer_%20Insights%20From%20Joint%20Modeling%20and%20Large-Scale%20Data%20Analysis.pdf" id="file-5198474-4477917">
                <date notBefore="2025-08-04"/>
              </ref>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="153845">
                <persName>
                  <forename>Sebastien</forename>
                  <surname>Benzekry</surname>
                </persName>
                <email type="md5">6265406c2f4b74e0106bf0ba27675c40</email>
                <email type="domain">inria.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-05198474</idno>
            <idno type="halUri">https://inria.hal.science/hal-05198474</idno>
            <idno type="halBibtex">schneider:hal-05198474</idno>
            <idno type="halRefHtml">&lt;i&gt;CPT: Pharmacometrics and Systems Pharmacology&lt;/i&gt;, 2025, &lt;a target="_blank" href="https://dx.doi.org/10.1002/psp4.70079"&gt;&amp;#x27E8;10.1002/psp4.70079&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">CPT: Pharmacometrics and Systems Pharmacology, 2025, &amp;#x27E8;10.1002/psp4.70079&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 - Attribution<ref corresp="#file-5198474-4477917"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="INSU">INSU - Institut National des Sciences de l'Univers</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="INRIA">INRIA - Institut National de Recherche en Informatique et en Automatique</idno>
            <idno type="stamp" n="UNIV-AMU">Aix Marseille Université</idno>
            <idno type="stamp" n="CNES">CNES - Centre national d'études spatiales</idno>
            <idno type="stamp" n="INRIA-SOPHIA">INRIA Sophia Antipolis - Méditerranée</idno>
            <idno type="stamp" n="LAM" corresp="OSU-INSTITUT-PYTHEAS">Laboratoire d' Astrophysique de Marseille</idno>
            <idno type="stamp" n="INRIASO">INRIA-SOPHIA</idno>
            <idno type="stamp" n="INRIA_TEST">INRIA - Institut National de Recherche en Informatique et en Automatique</idno>
            <idno type="stamp" n="OSU-INSTITUT-PYTHEAS">OSU INSTITUT PYTHEAS</idno>
            <idno type="stamp" n="TESTALAIN1">TESTALAIN1</idno>
            <idno type="stamp" n="INRIA2">INRIA 2</idno>
            <idno type="stamp" n="TDS-MACS">Réseau de recherche en Théorie des Systèmes Distribués, Modélisation, Analyse et Contrôle des Systèmes</idno>
            <idno type="stamp" n="UNIV-COTEDAZUR">Université Côte d'Azur</idno>
            <idno type="stamp" n="CRCM">Centre de Recherche en Cancérologie de Marseille</idno>
            <idno type="stamp" n="ANR">ANR</idno>
            <idno type="stamp" n="INRIA-ETATSUNIS">Copublications Inria-Etats-Unis</idno>
            <idno type="stamp" n="PEPR_SANTENUM">PEPR Santé numérique</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Optimizing First‐Line Therapeutics in Non‐Small Cell Lung Cancer: Insights From Joint Modeling and Large‐Scale Data Analysis</title>
                <author role="crp">
                  <persName>
                    <forename type="first">Benjamin</forename>
                    <forename type="middle">K</forename>
                    <surname>Schneider</surname>
                  </persName>
                  <email type="md5">efd5d31bb6abacaff820a62dda788aca</email>
                  <email type="domain">gmail.com</email>
                  <idno type="idhal" notation="numeric">1569323</idno>
                  <idno type="halauthorid" notation="string">1571428-1569323</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-5544-3499</idno>
                  <affiliation ref="#struct-179944"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Sébastien</forename>
                    <surname>Benzekry</surname>
                  </persName>
                  <email type="md5">058c3fc27bb7f758cba0c0195d61a833</email>
                  <email type="domain">phare.normalesup.org</email>
                  <idno type="idhal" notation="string">sebastien-benzekry</idno>
                  <idno type="idhal" notation="numeric">12116</idno>
                  <idno type="halauthorid" notation="string">9370-12116</idno>
                  <idno type="ARXIV">https://arxiv.org/a/benzekry_s_1</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-3749-8637</idno>
                  <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=xsLpdFAAAAAJ&amp;hl=fr&amp;oi=ao</idno>
                  <idno type="IDREF">https://www.idref.fr/159344212</idno>
                  <affiliation ref="#struct-1071285"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Jonathan</forename>
                    <forename type="middle">P</forename>
                    <surname>Mochel</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">1211549</idno>
                  <idno type="halauthorid" notation="string">1810566-1211549</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-0997-3111</idno>
                  <affiliation ref="#struct-302747"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">121435</idno>
                <idno type="issn">2163-8306</idno>
                <idno type="eissn">2163-8306</idno>
                <title level="j">CPT: Pharmacometrics and Systems Pharmacology</title>
                <imprint>
                  <publisher>American Society for Clinical Pharmacology and Therapeutics ;  International Society of Pharmacometrics</publisher>
                  <date type="datePub">2025-07-29</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1002/psp4.70079</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">NSCLC</term>
                <term xml:lang="en">resistance</term>
                <term xml:lang="en">population pharmacokinetics-pharmacodynamics</term>
                <term xml:lang="en">non-small cell lung cancer</term>
                <term xml:lang="en">non-linear mixed effects</term>
                <term xml:lang="en">model based meta analysis</term>
                <term xml:lang="en">methodology</term>
                <term xml:lang="en">mathematical modeling</term>
                <term xml:lang="en">lung cancer</term>
              </keywords>
              <classCode scheme="halDomain" n="info.info-mo">Computer Science [cs]/Modeling and Simulation</classCode>
              <classCode scheme="halDomain" n="sdv.can">Life Sciences [q-bio]/Cancer</classCode>
              <classCode scheme="halDomain" n="sdv.sp.pharma">Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology</classCode>
              <classCode scheme="halDomain" n="stat">Statistics [stat]</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Non-small cell lung cancer (NSCLC) is often intrinsically resistant to several first-and second-line therapeutics and can rapidly acquire further resistance after a patient begins treatment. Treatment outcomes are, therefore, significantly impacted by the optimization of scheduling. Previous preclinical research has suggested that scheduling bevacizumab sequentially with combination antiproliferatives could improve clinical outcomes. Mathematical modeling is a well-suited tool for investigating this proposed modification. To address this critical need, individual patient tumor data from 11 clinical trials in NSCLC have been collated and used to develop a semi-mechanistic model of NSCLC growth and response to the therapeutics represented in those trials. Precise estimates of clinical parameters fundamental to cancer modeling have been produced, such as the rate of acquired resistance to various pharmaceuticals, the relationship between drug concentration and cancer cell death, as well as the fine dynamics of vascular remodeling in response to bevacizumab. In a reserved portion of the dataset, this model predicted the efficacy of individual treatment time courses with an average difference between final prediction and observation of 59.7% after a single tumor measurement and 11.7% after three successive tumor measurements. A delay of 9.6 h between pemetrexed-cisplatin and bevacizumab administration is predicted to optimize the benefit of sequential administration. At this gap, approximately 93.5% of simulated patients benefited from a gap in administration compared with concomitant administration. Of those simulated patients, the mean improvement in tumor reduction was 20.7%. This suggests that scheduling a modest gap between the administration of bevacizumab and partner antiproliferatives could meaningfully improve patient outcomes in NSCLC.&lt;p&gt;This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.&lt;/p&gt;</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-179944" status="VALID">
          <idno type="IdRef">157042596</idno>
          <idno type="ISNI">0000000406147900</idno>
          <idno type="RNSR">201220274P</idno>
          <idno type="ROR">https://ror.org/00ssy9q55</idno>
          <orgName>Laboratoire d'Astrophysique de Marseille</orgName>
          <orgName type="acronym">LAM</orgName>
          <date type="start">2012-01-01</date>
          <desc>
            <address>
              <addrLine>Pôle de l'Étoile Site de Château-Gombert 38, rue Frédéric Joliot-Curie 13388 Marseille cedex 13</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.lam.fr/</ref>
          </desc>
          <listRelation>
            <relation name="UMR7326" active="#struct-198056" type="direct"/>
            <relation active="#struct-300045" type="direct"/>
            <relation name="UMR7326" active="#struct-307314" type="direct"/>
            <relation name="UMR7326" active="#struct-441569" type="direct"/>
          </listRelation>
        </org>
        <org type="researchteam" xml:id="struct-1071285" status="VALID">
          <idno type="RNSR">202124080M</idno>
          <idno type="ROR">https://ror.org/02c7vb662</idno>
          <orgName>Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique</orgName>
          <orgName type="acronym">COMPO</orgName>
          <date type="start">2021-05-01</date>
          <date type="end">2027-12-31</date>
          <desc>
            <address>
              <addrLine>Inria Sophia Antipolis Méditerranée2004 Route des Lucioles06902 Valbonne</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-34586" type="direct"/>
            <relation active="#struct-300009" type="indirect"/>
            <relation active="#struct-179570" type="direct"/>
            <relation name="UM105" active="#struct-198056" type="indirect"/>
            <relation name="UMR7258" active="#struct-301325" type="indirect"/>
            <relation active="#struct-301051" type="indirect"/>
            <relation name="U1068" active="#struct-303623" type="indirect"/>
            <relation name="UMR7258" active="#struct-441569" type="indirect"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-302747" status="VALID">
          <idno type="ROR">https://ror.org/04rswrd78</idno>
          <orgName>Iowa State University</orgName>
          <orgName type="acronym">ISU</orgName>
          <desc>
            <address>
              <addrLine>Ames, Iowa 50011</addrLine>
              <country key="US"/>
            </address>
            <ref type="url">https://www.iastate.edu</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-198056" status="VALID">
          <idno type="IdRef">15863621X</idno>
          <idno type="ISNI">0000 0001 2176 4817</idno>
          <idno type="ROR">https://ror.org/035xkbk20</idno>
          <orgName>Aix Marseille Université</orgName>
          <orgName type="acronym">AMU</orgName>
          <date type="start">2012-01-01</date>
          <desc>
            <address>
              <addrLine>Aix-Marseille UniversitéJardins du Pharo58 Boulevard Charles Livon13284 Marseille cedex 7</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-amu.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300045" status="VALID">
          <idno type="IdRef">029349265</idno>
          <idno type="ISNI">0000 0001 2154 1736</idno>
          <idno type="ROR">https://ror.org/04kdfz702</idno>
          <idno type="Wikidata">Q3152437</idno>
          <orgName>Institut national des sciences de l'Univers</orgName>
          <orgName type="acronym">INSU - CNRS</orgName>
          <date type="start">2007-04-19</date>
          <desc>
            <address>
              <addrLine>INSU-CNRS3 rue Michel-Ange, 75794 Paris Cedex 16</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.insu.cnrs.fr</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-307314" status="VALID">
          <orgName>Centre National d'Études Spatiales [Toulouse]</orgName>
          <orgName type="acronym">CNES</orgName>
          <desc>
            <address>
              <addrLine>18 avenue Edouard Belin 31401 Toulouse</addrLine>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-34586" status="VALID">
          <idno type="RNSR">198318250R</idno>
          <idno type="ROR">https://ror.org/01nzkaw91</idno>
          <orgName>Centre Inria d'Université Côte d'Azur</orgName>
          <desc>
            <address>
              <addrLine>2004 route des Lucioles BP 93 06902 Sophia Antipolis</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inria.fr/centre/sophia/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300009" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300009" status="VALID">
          <idno type="ROR">https://ror.org/02kvxyf05</idno>
          <orgName>Institut National de Recherche en Informatique et en Automatique</orgName>
          <orgName type="acronym">Inria</orgName>
          <desc>
            <address>
              <addrLine>Domaine de VoluceauRocquencourt - BP 10578153 Le Chesnay Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inria.fr/en/</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-179570" status="VALID">
          <idno type="RNSR">201220152G</idno>
          <idno type="ROR">0494jpz02</idno>
          <orgName>Centre de Recherche en Cancérologie de Marseille</orgName>
          <orgName type="acronym">CRCM</orgName>
          <date type="start">2012</date>
          <desc>
            <address>
              <addrLine>27 bd Leï Roure, BP 30005913273 Marseille Cedex 09</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://crcm.marseille.inserm.fr/spip.php?article314</ref>
          </desc>
          <listRelation>
            <relation name="UM105" active="#struct-198056" type="direct"/>
            <relation name="UMR7258" active="#struct-301325" type="direct"/>
            <relation active="#struct-301051" type="indirect"/>
            <relation name="U1068" active="#struct-303623" type="direct"/>
            <relation name="UMR7258" active="#struct-441569" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-301325" status="VALID">
          <idno type="ROR">https://ror.org/04s3t1g37</idno>
          <orgName>Institut Paoli-Calmettes</orgName>
          <orgName type="acronym">IPC</orgName>
          <desc>
            <address>
              <addrLine>232 Boulevard de Sainte-Marguerite13009 Marseille</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.institutpaolicalmettes.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-301051" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-301051" status="VALID">
          <orgName>Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
      </listOrg>
      <listOrg type="projects">
        <org type="anrProject" xml:id="projanr-98243" status="VALID">
          <idno type="anr">ANR-22-PESN-0017</idno>
          <orgName>DIGPHAT</orgName>
          <desc>Multi-scale and longitudinal data modeling in pharmacology: toward digital pharmacological twins</desc>
          <date type="start">2022</date>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>